Small Business: Cancer Diagnostics and Treatments (CDT) OTC-H (10-14)
The Oncology 2 – Translational Clinical Small Business Activities Special Emphasis Panels [OTC SBIR/STTR SEPs] review small business applications including Small Business Innovation Research [SBIR] and Small Business Technology Transfer [STTR] grant applications concerned with basic, preclinical, and clinical studies in the oncological sciences.
Scientific Review Officer
Cancer Diagnostics and Treatments SBIR/STTR SEP
[CDT OTC-H (10-14)]
This Special Emphasis Panel reviews grant applications related to diagnosis and treatment of cancer. This includes biomarkers as prognosticators of cancer, bioimmunotherapies of cancer, and novel approaches to treating cancer.
The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
Topics
- Discovery and validation of biomarkers for cancer detection, diagnosis and prognosis
- Novel assays, instrumentation and analysis algorithm for cancer screening, and metastasis and survival prediction
- Basic, pre-clinical and clinical testing for tumor genetic and epigenetic variations
- Development and evaluation of cancer immunotherapeutic strategies in preclinical models, and translational studies leading to pilot and/or phase-1 clinical trials
Shared Interests and Overlaps
- Interdisciplinary Molecular Sciences and Training (IMST)
- Immunology SBIR/STTR SEP [IMM-G]
- Digestive Sciences SBIR/STTR SEP [DIG (10)]
- Respiratory Sciences SBIR/STTR SEP [RES (10)]
